Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2359
  • Dowloads 123

Original Research

Open Access

Treatment and outcome of Stage I A1 squamous carcinoma of the cervix: a clinicopathologic study of 346 cases

  • M.R. Liang1,2
  • S.Y. Zeng1,2,*,
  • W. Jiang2
  • L. Li2
  • M.L. Zhong2
  • O.P. Huang3

1Medical College of Nanchang University, Nanchang, PR China

2Department of Gynecologic Oncology, Jiangxi Maternal and Child Health Hospital, Nanchang, PR China

3Department of Gynecology, Jiangxi Maternal and Child Health Hospital, Nanchang, PR China

DOI: 10.12892/ejgo3154.2016 Vol.37,Issue 6,December 2016 pp.775-780

Published: 10 December 2016

*Corresponding Author(s): S.Y. Zeng E-mail: jacksonzeng@yeah.net

PDF (291.05 kB) View Full-text

Abstract

Objective: To analyze the clinicopathologic feature of Stage I A1 squamous carcinoma of the cervix (SCC) and to explore the outcome of different surgical methods. Materials and Methods: Clinicopathological data of 346 cases with Stage I A1 SCC diagnosed between November 2nd, 1995 and December 31st, 2011 were reviewed and analyzed. Results: As major diagnostic method, 44.5% (154/346) patients accepted cold knife conization (CKC), while 58.1% (201/346) patient took total hysterectomy (TH) as their final surgical methods. The trend in treatment methods from 1995 to 2011 revealed that increasing cases were treated with CKC, modified radical hysterectomy (MRH) obviously reduced, while the proportion treated by TH remained unchanged. Due to a small number of cases receiving vaginal trachelectomy (VT) and radical trachelectomy (RT), the authors did not find any obvious changes. Prognosis: The overall recurrence rate was 1.2% (4/346). The overall survival rates for CKC, VT, TH, MRH, and RT were 100%, 100%, 98.2%, 100%, and 100%, and the difference was not statistically significant (p = 0.819). The incidence rate of LVSI was 4.9% (17/346), the overall survival rates for patients with LVSI and without LVSI were 99.3% and 93.3%, respectively, and there was statistical difference between them (p = 0.003). Univariate analysis showed that only LVSI was an important predictor for survival (p = 0.030). Conclusions: the treatments for Stage I A1 SCC are becoming more conservative, and individualized therapy and more frequent surveillance should be administrated to those patients with LVSI.

Keywords

Microinvasive carcinoma of the cervix; Surgical treatment; Prognosis; Lymphovascular space invasion.

Cite and Share

M.R. Liang,S.Y. Zeng,W. Jiang,L. Li,M.L. Zhong,O.P. Huang. Treatment and outcome of Stage I A1 squamous carcinoma of the cervix: a clinicopathologic study of 346 cases. European Journal of Gynaecological Oncology. 2016. 37(6);775-780.

URL:

https://www.ejgo.net/articles/10.12892/ejgo3154.2016

References

[1] Cairns M., Cruickshank.: “A review of women with microinvasive cervical cancer in the Grampian region”. J. Low. Genit. Tract. Dis. 2007, 11, 290.

[2] Wu Y.Y., Liang M.R., Li L.Y., Zeng S.Y.: “Analysis of 4223 hospitalized patients with cervical cancer during 1990-2007”. Zhonghua. Fu. Chan. Ke. Za. Zhi. 2008, 43, 433. [in Chinese]

[3] Zhang W.H.: “Advanced and recurrent cervical cancer”. In: Lian L.J., (ed). Lin Qiao Zhi Gynecologic Oncology. Peking: People’s medical publishing house, 2006, 394. [in Chinese]

[4] Tseng C.J., Chang C.C., Tseng C.C., Hou H.C., Wang C.B., Chen C.H., et al.: “Loop conization for the treatment of microinvasive carcinoma of the cervix”. Int. J. Gynecol. Cancer. 2006, 16, 1574.

[5] Yao F.F., Qian M., Xing Y., Zhou B.B., You Z.X., et al.: “Discussion of the clinical diagnosis and treatment in 61 stage A1 squamous cell cervical carcinoma”. Progress in Obstetrics and. Gynecology, 2013, 22, 60. [in Chinese].

[6] Elliott P., Coppleson M., Russell P., Liouros P., Carter J., MacLeod C., et al. “Early invasive (FIGO stagcinoma of the cervix: a clinico- pathologic study of 476 cases”. Int. J. Gynecol. Cancer, 2000. 10, 42.

[7] Zeng S.Y., Liang M.R., Li L.Y., Li L., Jiang W., Zhong M.L.: “Application of transvaginal external fascia trachelectomy in the treatment of CIN and micro-invasive cervical cancer”. Zhonghua. Zhong. Liu. Za. Zhi., 2013, 35, 543. [in Chinese].

[8] Benedet J.L., Anderson G.H.: “Stage IA carcinoma of the cervix revisited”. Obstet. Gynecol., 1996, 87, 1052.

[9] Raspagliesi F., Ditto A., Solima E., Quattrone P., Fontanelli R., Zanaboni F., et al.: “Microinvasive squamous cell cervical carcinoma”. Crit. Rev. Oncol. Hematol., 2003, 48, 251.

[10] Haller H., Krašević M., Mamula O., Brnčić-Fischer A., Eminović S., Manestar M.: “Treatment and outcome of stage Ia1 squamous cell carcinoma of the uterine cervix”. Int. J. Gynaecol. Obstet., 2011, 113, 72.

[11] Chen J.R., Chiu M.L., Wang T.Y., Chen T.C., Wang K.G., Su T.H., et al.: “Is conization once following by simple hysterectomy sufficient for all clinical stage IA1 cervical squamous cell carcinoma?”Taiwan. J. Obstet. Gynecol. 2013, 52, 385.

[12] Dedes K.J., Dedes M., Varga Z., Zimmermann D.R., Fink D., Fehr M.K.: “Curative treatment of a pelvic side wall recurrence after conization for microinvasive cervical cancer stage IA1: a case report and review of the literature”. J. Low. Genit. Tract. Dis., 2007, 11, 177.

[13] Raspagliesi F., Ditto A., Quattrone P., Solima E., Fontanelli R., Dousias V., et al.: “Prognostic factors in microinvasive cervical squamous cell cancer: long-term results”. Int. J. Gynecol. Cancer, 2005, 15, 88.

Submission Turnaround Time

Top